Cardiff Oncology, Inc. (CRDF) has 37 open-market insider trades by 12 insiders since 2020. Over the last six months insiders net bought $1.1M. The most active filer is Gary W. Pace, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Gary W. Pace | Dir | — | 13 | $4.6M | 2026-07-14 |
| Vicki Kelemen | COOVP | — | 2 | $1.3M | 2021-03-23 |
| James E. Levine | CFO | — | 3 | $278K | 2024-12-18 |
| Lale White | Dir | — | 2 | $225K | 2022-09-19 |
| Mani Mohindru | CEO | — | 2 | $80K | 2026-07-14 |
| James O. Armitage | Dir | — | 3 | $79K | 2022-09-16 |
| Rodney S. Markin | Dir | — | 2 | $60K | 2021-03-26 |
| Renee P. Tannenbaum | Dir | — | 2 | $51K | 2024-12-12 |
| Gary S. Jacob | Dir | — | 2 | $50K | 2021-03-23 |
| John P. Brancaccio | Dir | — | 2 | $43K | 2021-03-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mani Mohindru | CEO | Buy | $50K | 2026-07-14 |
| Gary W. Pace | Director | Buy | $1000K | 2026-07-14 |
| Mani Mohindru | CEO | Buy | $30K | 2026-06-18 |
| Gary W. Pace | Director | Buy | $37K | 2026-06-18 |
| Gary W. Pace | Director | Buy | $711K | 2025-07-30 |
| James E. Levine | CFO | Buy | $37K | 2024-12-16 |
Companies that share insiders with CRDF, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Renee P. Tannenbaum | Director | Buy | $34K | 2024-12-12 |
| Gary W. Pace | Director | Buy | $940K | 2024-12-11 |
| Gary W. Pace | Director | Buy | $41K | 2023-12-19 |
| Gary W. Pace | Director | Buy | $22K | 2023-11-10 |
| Mark Erlander | CEO | Buy | $14K | 2022-11-25 |
| Lale White | Director | Buy | $25K | 2022-09-19 |
| James E. Levine | CFO | Buy | $47K | 2022-09-16 |
| James O. Armitage | Director | Buy | $20K | 2022-09-16 |
| Gary W. Pace | Director | Buy | $257K | 2022-09-15 |